Filing Flows › Xenetic Biosciences (XBIO) › Q2 2026 › vs Q2 2025
Xenetic Biosciences (XBIO) Q2 2026 vs Q2 2025 (year over year)
Xenetic Biosciences's revenue rose $71K (+12%) from $590K in Q2 2025 to $661K in Q2 2026.
Xenetic Biosciences, Q2 2026: revenue $661K (+12% year over year), operating margin -147.1%, net loss $930K, operating cash flow −$875K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $661K | $590K | $71K | +12% |
| Other income, net | $42K | $36K | $6K | +18% |
| Net loss | $930K | $689K | $241K | +35% |
| Costs & expenses | $1.6M | $1.3M | $318K | +24% |
| Operating costs | $1.6M | $1.3M | $318K | +24% |
| Research & development | $552K | $657K | −$105K | -16% |
| General & admin | $1.1M | $658K | $423K | +64% |
| Operating cash sources | $930K | $689K | $241K | +35% |
| Share-based compensation | $52K | $16K | $36K | +231% |
| Working capital & other | $2K | $289K | −$287K | -99% |
| Cash used in operations | $875K | $384K | $492K | +128% |
| Net loss absorbed | $930K | $689K | $241K | +35% |
Questions
How much did Xenetic Biosciences's revenue grow year over year in Q2 2026?
Xenetic Biosciences's revenue rose $71K (+12%) from $590K in Q2 2025 to $661K in Q2 2026.